ZEISS Vision Care presents interim results on ZEISS MyoActive at ARVO 2026, Denver; 0.38D and 0.15mm reduction vs SV lenses.
ZEISS Vision Care presents interim results on ZEISS MyoActive at ARVO 2026, Denver; 0.38D and 0.15mm reduction vs SV lenses. ZEISS to Present New Clinical Study Results on Novel Myopia Management Lens ZEISS MyoActive at ARVO 2026 ZEISS to Present New Clinical Study Results on Novel Myopia Management Lens ZEISS MyoActive at ARVO 2026 Aalen, Germany | 5 May 2026 | ZEISS Vision Care New interim study data from ZEISS’s myopia control portfolio shows ZEISS MyoActive demonstrating high efficacy in slowing myopia progression. In addition, ZEISS presents first clinical insights on ZEISS MyoEase lenses, as well as the latest clinical results from the established ZEISS MyoCare portfolio. ...